Proposed amendments to the "Regulations on Fees for Pharmaceutical Approvals, etc."; (10 page(s), in Korean)

Draft FDA Circular entitled "Abridged Processing of Application for Registration/Notification of Medical Devices Approved by National Regulatory Authority of Any ASEAN Member Country"; (4 page(s), in English)

Draft Commission Implementing Decision not approving 5-chloro-2-methyl-2H-isothiazol-3- one (CIT) as an active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council; (4 page(s), in English)